Ledraxen

Enoxaparin sodium, the active ingredient in Ledraxen, is a low molecular weight heparin presented as a sterile injectable for subcutaneous, intravenous, or haemodialysis use. It is employed to prevent and treat venous thromboembolism in at‑risk patients.

GNH USA supplies Ledraxen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and specialty clinics worldwide, ensuring quality and regulatory adherence. The company manages cold‑chain logistics where required and provides comprehensive documentation for import and compliance. Clients benefit from competitive pricing and responsive technical support.

Enoxaparin sodium is a low molecular weight heparin used to manage venous thromboembolism.

Deep vein thrombosis (DVT) prevention: reduces clot formation in patients at risk of lower‑limb thrombosis. Pulmonary embolism (PE) treatment: facilitates clot resolution and prevents recurrence. Anticoagulation during hemodialysis: maintains circuit patency by inhibiting clotting. Surgical prophylaxis: lowers postoperative venous thromboembolism risk in orthopedic and general surgery patients.

Enoxaparin sodium may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Injection site bruising or hematoma - Minor bleeding (e.g., gum, nosebleeds) - Nausea or vomiting - Headache

Serious or Rare Side Effects: - Major hemorrhage (internal or intracranial) - Thrombocytopenia (heparin‑induced) - Spinal or epidural hematoma - Severe allergic reaction (anaphylaxis)

When using Ledraxen, several precautions should be observed to minimize risk.

Renal impairment: assess function and consider dose adjustment. Bleeding risk: evaluate for active bleeding or recent surgery before initiating. Concomitant anticoagulants: avoid or use with caution when combined with other anticoagulants or antiplatelet agents. Pregnancy: use only if benefit outweighs potential risk; data limited. Spinal/epidural procedures: discontinue before neuraxial anesthesia to reduce hematoma risk. Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Enoxaparin sodium